Home/Filings/4/0001209191-19-058936
4//SEC Filing

COHEN RON 4

Accession 0001209191-19-058936

CIK 0001008848other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 7:47 AM ET

Size

6.0 KB

Accession

0001209191-19-058936

Insider Transaction Report

Form 4
Period: 2019-12-02
COHEN RON
President and CEO
Transactions
  • Sale

    Common Stock

    2019-12-02$1.60/sh4,699$7,505607,287 total
Holdings
  • Common Stock

    (indirect: By Trust)
    25,150
Footnotes (3)
  • [F1]Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.53 to $1.67 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The shares are held in a grantor retained annuity trust which was established by the reporting person and of which he is the sole trustee.

Issuer

ACORDA THERAPEUTICS INC

CIK 0001008848

Entity typeother

Related Parties

1
  • filerCIK 0001272354

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:47 AM ET
Size
6.0 KB